HOXB9 a miR-122–5p regulated gene, suppressed the anticancer effects of brusatol by upregulating SCD1 expression in melanoma
Open Access
- 7 April 2023
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 162, 114650
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (2021-MS-288)
- National Natural Science Foundation of China (81874136)
- National Natural Science Foundation of China (81973603)
- National Natural Science Foundation of China (82073070)
This publication has 36 references indexed in Scilit:
- Regulation of Cancer Stem Cell Self-Renewal by HOXB9 Antagonizes Endoplasmic Reticulum Stress-Induced Melanoma Cell Apoptosis via the miR-765–FOXA2 AxisJournal of Investigative Dermatology, 2018
- Emerging role of lipid metabolism alterations in Cancer stem cellsJournal of Experimental & Clinical Cancer Research, 2018
- MiR-122-5p inhibits cell migration and invasion in gastric cancer by down-regulating DUSP4Cancer Biology & Therapy, 2018
- Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling PathwayOxidative Medicine and Cellular Longevity, 2018
- Cancer stem cells revisitedNature Medicine, 2017
- Brusatol-Mediated Inhibition of c-Myc Increases HIF-1α Degradation and Causes Cell Death in Colorectal Cancer under HypoxiaTheranostics, 2017
- X-ray structure of a mammalian stearoyl-CoA desaturaseNature, 2015
- HOXB9 promotes epithelial-to-mesenchymal transition via transforming growth factor-β1 pathway in hepatocellular carcinoma cellsClinical and Experimental Medicine, 2014
- Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanismProceedings of the National Academy of Sciences, 2011
- Biochemical and physiological function of stearoyl-CoA desaturaseAmerican Journal of Physiology-Endocrinology and Metabolism, 2009